Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Provides SOLiD Platform for University of Strasbourg's Genomax Project


Life Technologies said last month that its SOLiD platform is "supporting" the Genomax project of the University of Strasbourg, France, to study diseases such as diabetes, obesity, asthma, and arterial hypertension.

Genomax, funded with €1.1 million ($1.4 million) from the University of Strasbourg, the regional government, and others, is part of Biomax, a translational biobank project to enable the storage and analysis of thousands of human samples.

According to Seiamak Bahram, head of Genomax and a professor of immunology at Strasbourg University Hospital, "hundreds" of blood samples have been sequenced on the SOLiD platform, providing "an invaluable insight into the most common diseases."

Life Tech's director of digital PCR in Europe, Herve Pouzoullic, said in a statement that the company "is proud to be supplying" its products to Genomax, including its SOLiD sequencing and Open Array Real-Time PCR platforms.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.